ライフサイエンスコーパス: continued

1 It is not known whether this trend has continued.

2 ar 200 mg/day while ursodeoxycholic acid was continued.

3 as their concentrations decreased as storage continued.

4 , had been suggested to be responsible for a continued ability to arrest by inhibiting E2f activity a

5 ong-lasting recovery of movement despite the continued absence of dopamine.

6 ile X Syndrome (FX) can be attributed to the continued absence of FMRP from the PFC, independent of F

7 al dysregulation from dysfunction due to the continued absence of FMRP is necessary to understand the

8 Patients from continued access observational studies were included for

9 ed in 365 patients (96 initial registry, 269 continued access patients).

10 n undergoing TAVR in the PARTNER 1 trial and continued access registries was conducted in 25 centers

11 Aortic Transcatheter Valves) 2 VIV trial and continued access registries.

12 from the initial registry to the subsequent continued access registry, both at 30 days (8.2% vs. 0.7

13 ome adaptations in the hand that facilitated continued access to forest canopy may have complemented,

14 Continued activation of cell survival factors, Atf6 and

15 ming during late stages of infection despite continued activation of the eIF2alpha signaling pathway.

16 heir size and impact crater density indicate continued activity over billions of years, their formati

17 edural efficacy can best be improved through continued advancements in ablation technology and strate

18 Continued advancements in sequencing technologies have f

19 pediatric patient's family requested care be continued after declaration of death by neurologic crite

20 While forest loss and fire continued after RSPO certification, certified palm oil w

21 agonism, where residual receptor activation continued after washout.

22 n vascular surgery also began before DHR but continued afterward as well: 148 cases/resident in the l

23 ved after the initial decline from peak with continued agonist exposure.

24 ailable software tool was developed to allow continued analyses of these and other transcriptional pr

25 d these studies could serve as the basis for continued analysis of structure-activity relationships a

26 ndscapes may turn into net CO2 sources under continued anthropogenic CO2 emissions.

27 r results imply a dynamic EAIS response with continued anthropogenic warming and suggest that the EAI

28 conditions similar to those anticipated with continued anthropogenic warming.

29 with venous thromboembolism in equipoise for continued anticoagulation, the risk of a recurrent event

30 and were in equipoise regarding the need for continued anticoagulation.

31 b (15 mg/kg of bodyweight) every 3 weeks and continued as maintenance every 3 weeks until disease pro

32 rted emission inventories, and can serve for continued assessment of future changes in emissions inde

33 Assuming mixed-layer carbonate production continued at Maud Rise, we deduce the PETM onset was lik

34 nd must demonstrate leadership to ensure the continued availability of and the ethical use of researc

35 lizumab after long-term treatment results in continued benefit, as evidenced by improved symptom cont

36 he absence of progression, patients in arm B continued bevacizumab alone until disease progression or

37 mice enabling longitudinal TFAR profiling by continued bioimaging throughout the lives of the animals

38 be ongoing and underscores the importance of continued biomonitoring and research efforts to elucidat

39 Continued biomonitoring of these bisphenols in populatio

40 etween 20% and 36% of the adverse effects of continued cannabis use on outcome in psychosis might be

41 tion adherence partly mediated the effect of continued cannabis use on outcome, including risk of rel

42 ion adherence partly mediated the effects of continued cannabis use on risk of relapse.

43 Continued cannabis use predicted poor outcome, including

44 ical therapies for ARDS, however, presents a continued challenge in the field.

45 PPI dose escalation and continued chronic therapy in those unresponsive to initi

46 a viruses represent a pandemic threat due to continued circulation in wild birds and limited immunity

47 ensify tOPV use prior to OPV2 cessation show continued circulation of serotype 2 vaccine-derived poli

48 While continued climate warming is expected to increase the ca

49 These findings support continued clinical development of this potential therape

50 ks of postoperative bleeding associated with continued clopidogrel use and those associated with cess

51 ot having sex on first meeting, while living/continued communication with sexual partner(s) was assoc

52 ay) was injected 3 hours post-MI for (d)1 or continued daily till d5.

53 These properties were lost with continued decomposition at later phases of ripening.

54 ntiated effector cells and renews itself for continued defense.

55 istent public health threat because of their continued detection in poultry and ability to cause huma

56 Our work provides a rationale for continued development of a structural framework for the

57 barriers need to be addressed to ensure the continued development of future surgeon-scientists.

58 This finding will lead to continued development of quantitative US, which can be u

59 mmitted thymocytes is a critical process for continued development of these cells, and is mediated by

60 ein provides an essential foundation for the continued development of this important class of reactio

61 he expression of adipogenic target genes and continued differentiation.

62 effect of chronic HFD on beta-cells, wherein continued DNA damage owing to persistent oxidative stres

63 longed, unresolved stress was accompanied by continued down-regulation of VIL1 and GSN, resulting in

64 n of intake, sensitized motivation for drug, continued drug use in the face of adverse consequences,

65 Allergen challenge was continued during HOCl hydrogel application.

66 or STEM careers threatens the United States' continued economic progress.

67 Continued efforts are needed to improve patient selectio

68 rtant for monitoring emerging strains in our continued efforts to reduce the overall burden of norovi

69 With the continued emergence of risk loci from Genome-Wide Associ

70 Continued empiric treatment without POC testing was proj

71 To underscore the need for continued empirical attention to net worth, we review tr

72 ines for this disease offers a framework for continued enhancement of the outcome for patients.

73 arcinoma cancers are encouraging and support continued evaluation of anti-EGFR antibodies in this sub

74 A continued excess mortality occurred after perforation, w

75 Continued expansion in the size and dimensionality of ca

76 , our study highlights the importance of the continued expansion of minority cohorts.

77 The continued expansion of the fields of macromolecular chem

78 Missing a diagnosis of OA may lead to continued exposure to a causative agent and progressive

79 Using this model, they demonstrate that continued expression of oncogenic K-RAS is required for

80 tected-area network as a bulwark against the continued extinction of wild populations, species, and e

81 Since then, alongside the continued extraction of data from the medicinal chemistr

82 rden of elevated BMI highlights the need for continued focus on surveillance of BMI and identificatio

83 Continued follow-up is warranted.

84 seen in those patients in whom anakinra was continued for 12 weeks.

85 ays 5 to 14 to high-risk preterm infants and continued for 24 days, appears to be safe but did not im

86 Follow-up continued for 24 months minimum and 10 years maximum aft

87 fter 1 week as penile rehabilitation and was continued for 3 months.

88 s at higher dosages; (3) treatment should be continued for 6-12 months to potentially prevent relapse

89 tarted within 10 days after presentation and continued for 6-12 months.

90 c plugged catheter, antibiotic treatment was continued for 7 days.

91 rically at the time of rash presentation and continued for a median (interquartile range) of 14 (14-1

92 Treatment was continued for as long as the patients derived clinical b

93 oping age-related macular degeneration (AMD) continued for people born during the Baby Boom years (19

94 er 8 weeks, dexamethasone mouthwash could be continued for up to eight additional weeks at the discre

95 Improvements in MD continued from month 6 to month 12 of the IIHTT in all t

96 isk ratio, 0.905; 95% CI, 0.898-0.913), with continued gains through 1.75 years (risk ratio, 0.615; 9

97 by foot-shock stress, but in the absence of continued global elevations in H3K9me2.

98 e, in order to obtain nutrients required for continued growth and proliferation.

99 ng expression of AR-target genes that permit continued growth despite AR blockade.

100 Continued growth in emissions will adversely affect more

101 ing capability are the driving force towards continued growth of electrochemical biosensing platforms

102 of growth factors in tissue growth, and the continued growth of hydrogel enabled by diffusion of mon

103 tors, masticatory hyperfunction, trauma, and continued growth, but the underlying mechanism remains l

104 (ERalpha) and depend on estrogen signals for continued growth.

105 Eighty participants continued HA use and 14 discontinued HA use at the time

106 With continued high rates of adult obesity and DM along with

107 ions to address these aspects as well as the continued high shares of excess mortality due to alcohol

108 lity of AKT to activate HSF1 and demonstrate continued HSF1/HuR/Rictor signaling in the context of AK

109 o better understand the potential benefit of continued immune checkpoint inhibition beyond progressio

110 s for late allograft pancreatectomy while on continued immunosuppression for functional kidney allogr

111 We emphasise a continued important role for surgical treatment in certa

112 Continued improvement to 36-months postinjury was only p

113 onin-norepinephrine reuptake inhibitors were continued in ICU, complicating interpretation.

114 inosa density that began within 48 hours and continued in the first year of treatment.

115 se has changed dramatically, which has to be continued in the future.

116 us, help societies prepare for the projected continued increases in extremes.

117 Our projections show continued increases in longevity, and the need for caref

118 Continued input of observations into FRED to fill gaps i

119 Such measures, together with continued international efforts in education and trainin

120 Furthermore, continued interrogation of oncogenes in benign developme

121 DViSE trial recruited 7540 men, of whom 3786 continued into the cohort study.

122 ements in TB dynamics among the foreign-born continued into the coming decade.

123 cooling that started well before the EOT and continued into the Early Oligocene.

124 Finally, continued investigation into optimizing surgical outcome

125 Continued investigation into the mechanisms and outcomes

126 However, our findings provide a basis for continued investigation of BIIB074 in patients with trig

127 e is sufficiently strong evidence to support continued investigation of the potential benefits of hel

128 is review, we provide a rationale to support continued investment in Cryptococcus vaccine research, p

129 roblem highlights the critical importance of continued investment in LAIV development and creates an

130 itment is a business term that describes the continued investment of resources into a project even af

131 GES) is an iREC that promotes engagement and continued involvement in science among beginning undergr

132 The continued kidney allograft shortage has generated intere

133 h experiments demonstrated the effective and continued leaching of REEs by recycled citric acid, with

134 We report the continued lead (Pb) contamination of the Northwest Pacif

135 e control deficits in adulthood, and whether continued lifelong Mn exposure exacerbates these effects

136 affect >50% of animals in a population-have continued, likely due to involvement of multiple causal

137 e 400 mg every 28 days until progression and continued luteinising hormone-releasing hormone agonist

138 Notably, grafts showed evidence of continued maturation over the entire assessment period.

139 avior and quality of life than did those who continued medical therapy alone at 12 months.

140 -being will increasingly be based on health, continued mental stimulation, and consumption of cultura

141 p lifestyle sessions to all participants and continued metformin in the originally randomized metform

142 Continued molecular surveillance of noroviruses, includi

143 ges in MATS coverage underscore the need for continued monitoring of antigen expression and diversity

144 Findings show continued morbidity, including a high degree of comorbid

145 resulting in a feed-forward cascade in which continued mTORC2 activity is able to drive Rictor expres

146 rate of cardiovascular events than those who continued (multivariable-adjusted hazard ratio, 1.37; 95

147 and ill-conditioned sequences indicates the continued need for both thermodynamic model refinements

148 occurs in approximately 20%, indicating the continued need for more effective and less toxic therapi

149 and 26% grade 4 toxicity rates indicate the continued need for more-effective and less-toxic therapi

150 current understanding of AD in ACD, and the continued need to investigate the interplay between thes

151 on of the transcriptional responses requires continued NODAL/Activin signaling.

152 The continued observation of heterogeneity of treatment resp

153 alizumab was then discontinued, and subjects continued on 2000 mg of peanut protein.

154 If tolerated, subjects continued on 4000 mg of peanut protein daily.

155 At 12 weeks, patients continued on anakinra showed an improvement in peak Vo2

156 ified AHC or ovalbumin on alternate days and continued on HFD for another 10 weeks.

157 d agents, patients progressing with CLL were continued on ibrutinib for up to 3 months, with 19.8 mon

158 12; to week 56); participants on aflibercept continued on q8.

159 tching rules were met, although all patients continued on their originally assigned treatment.

160 describe transmission of influenza presents continued opportunity for analyses.

161 With an aging ESRD population and continued organ shortage, preservation of average post-t

162 the replication stress checkpoint, promoting continued origin firing.

163 ability Status Scale (EDSS) score increase)) continued original treatment (three times weekly (tiw) o

164 ith the basement membrane, but contribute to continued outgrowth through increased cell size.

165 ration was predicted to be more effective if continued over 2 years rather than 1 year, and if done a

166 success achieved in managing these patients, continued participation in available clinical trials in

167 r which [Formula: see text] increases due to continued photochemical aging, potentially resulting in

168 Continued PM10 exposure activated apoptosis and necrosis

169 ained inhibition of Ca(2+) transients in the continued presence of agonist, indicating the activation

170 ity of cholinergic SK responses requires the continued presence of extracellular calcium.

171 ) from baseline to 1 year, whereas there was continued progression in the control group (1.3 D differ

172 lar biology, and trait data for islands hold continued promise for unlocking many of the unresolved q

173 have had progression on enzalutamide with a continued prostate-specific antigen (PSA) rise after enz

174 break strain SPH2015 from Brazil resulted in continued protection against infection, no viral sheddin

175 contain added sugars, suggesting a need for continued public health efforts to support parents in ch

176 level of systemic resilience and aiding its continued recovery.

177 these data to future trends, we would expect continued reductions in malaria transmission, punctuated

178 Continued refinement of decision-making techniques is wa

179 Continued refinement to the model to reflect diverse bio

180 l-intrinsic senescence arrest to counter the continued regenerative stimuli.

181 6 km of stream across the region, as well as continued replacement of large-stream fishes by small-st

182 Beyond continued research and development of new drugs, a focus

183 There is substantial opportunity for continued research in this disease.

184 g those made in recent decades, will require continued research into mechanisms underlying disease pr

185 Continued research on CRF mutations will be critical for

186 It is anticipated that continued research will lead to a more comprehensive und

187 The continued rise in infections caused by extended-spectrum

188 relapsed, compared with 10 of 26 (38.5%) who continued risperidone (p<0.02).

189 discontinuation of risperidone compared with continued risperidone treatment.

190 indicative of elevated rigidity; yet despite continued ROCK2 activities/p-Mypt1 inactivation, progres

191 ls and hyperpolarization, but in response to continued signaling MORs undergo acute desensitization r

192 ursion are uncertain, especially the risk of continued spread, and the likely success of control meas

193 Continued strengthening of referral systems from HEWs an

194 direct contact model underscore the need for continued study of H7 subtype viruses.

195 in (MA)PbI3 demonstrates the promise of the continued study of halide perovskites under a range of t

196 l quality that provide encouragement for the continued study of ZnSnxGe1-xN2 alloys.

197 Continued study will be needed to evaluate the performan

198 The continued success of malaria control efforts requires th

199 Continued surveillance is warranted as the decision to i

200 Patients with continued symptoms can be evaluated with endoscopy and t

201 These issues highlight the need for continued synthesis between fossil and phylogenetic appr

202 clopidogrel had (compared with patients who continued the study medications) a lower risk of major c

203 Patients continued the trial regimen until treatment failure or u

204 supplementary immunization activities (SIAs) continued, the targeting of settlements at high risk for

205 crease body fat gain compared with girls who continued their low calcium intake.

206 ates to landscape restoration, and motivates continued theoretical development and empirical assessme

207 Continued therapy with teriparatide prevented the appear

208 s <2 or >/=2 both had lower rates of MI with continued thienopyridine (MI monthly incidence 0.16% ver

209 Reduction of MI or stent thrombosis with continued thienopyridine beyond 12 months versus placebo

210 y, those with DAPT scores >/=2 randomized to continued thienopyridine had greater reductions in MI or

211 on an aspirin regimen and were randomized to continued thienopyridine therapy vs placebo for 18 addit

212 mic benefit (relative to bleeding harm) with continued thienopyridine therapy, discontinuation at 12

213 ly cumulative incidence of MI was lower with continued thienopyridine versus placebo at 12 to 15 mont

214 merging pandemic influenza viruses present a continued threat to global public health.

215 0 mg twice daily) was started on day -10 and continued through day +100 post-HCT.

216 Surveillance continued through December 5, 2016.

217 Production of CH4 also commenced quickly but continued throughout the anaerobic interevent period and

218 ally tolerated beta-blocker therapy that was continued throughout the trial.

219 APAP administration began at 0 h and continued to 'ALF', defined as INR >3.

220 The mesoporous shells continued to act as regulators restricting the release o

221 Ferroelectric domain walls have continued to attract widespread attention due to both th

222 w-density lipoprotein level, statin exposure continued to be associated with a reduction in OAG risk.

223 Five patients continued to be followed up as of March 2017.

224 inal significance and approximately 75% that continued to be GWS in the transancestry analysis.

225 Benefits continued to be observed with longer-term treatment, and

226 on, institutional support, and collaborators continued to be positive influential factors.

227 of tacrolimus trough levels <5 ng/ml, which continued to be significant after adjustment for HLA-DR/

228 Allergy and atopic asthma have continued to become more prevalent in modern society des

229 ved a primary-site cCR to IC and 51 patients continued to cetuximab with IMRT 54 Gy.

230 ward the low intensity of the sated odor but continued to choose the high intensity of the nonsated o

231 t decrease significantly after the tear, but continued to decline compared with control eyes at all e

232 avenous chemotherapy agents had overuse that continued to decrease 6 months after the CW.

233 overage for polio, measles, and yellow fever continued to decrease, whereas the trend in coverage for

234 e and SCD animals during infection, SCD mice continued to deteriorate and failed to resolve the infec

235 In contrast, NE-treated rats continued to display accurate memory of the shock-contex

236 tered to half the patients, and all patients continued to exercise for 2 minutes at the same workload

237 However, only double-knockout mice continued to exhibit low liver Hamp at 8 weeks and faile

238 81 participants (29.5%; 95% CI, 25.9%-33.1%) continued to exhibit no clinical or laboratory evidence

239 alone under illumination by white light, and continued to exhibit superior catalytic properties follo

240 or a single "early burst" model, morphospace continued to expand following a slowdown in rates.

241 e rendered completely seizure-free and 48.8% continued to experience postoperative seizure symptoms.

242 feeder visits became fixed early while bees continued to experiment with the order of later visits.

243 amics and the presence and abundance of mice continued to fluctuate with human mobility through the t

244 he catastrophic loss of insulin, hep-tg mice continued to have significantly lower blood glucose.

245 Animals in group 1 continued to have weight gain and biochemical analyses c

246 -sensor retention at 6 hours (P = .003) that continued to increase at 24 hours after TAR (P = .0001).

247 As thaw in Soil warming continued to increase linearly, ground surface subsidenc

248 lowering of midstory trees and shrub species continued to increase with rising CO2 .

249 in 3 Hispanic persons with a chronic disease continued to lack coverage and access to care after ACA

250 We showed that ASM continued to mature until approximately 3 wk after birth

251 ns in the years 2015-2016 but sporadic cases continued to occur.

252 The formed gaps continued to propagate after composite light curing fini

253 terim analyses of KEYNOTE-006, pembrolizumab continued to provide superior overall survival versus ip

254 Among the remaining 49 patients, 16 continued to receive antibiotics, usually for infections

255 atients initially randomized to cyclosporine continued to receive cyclosporine-based immunosuppressio

256 After completion of chemotherapy, patients continued to receive rilotumumab or placebo monotherapy

257 alive; 27 (32%) and 11 (46%), respectively, continued to receive treatment.

258 g the UK, Canada, and Finland, however, have continued to recommend the use of the live vaccine.

259 Incidence rates not only continued to rise over the 10-year period from 1998-2002

260 rbon concentrations declining as consumption continued to rise.

261 Flies continued to search around the original location, even a

262 The chemotherapy plus bevacizumab groups continued to show significant improvement in OS compared

263 from clinical disease, while wild-type mice continued to show signs of disease.

264 Finally, internalized TCRs continued to signal and genetic modification of TCR inte

265 f Maine, white pine needle damage (WPND) has continued to spread and is now well established in all N

266 counting for these factors, the use of CRT-D continued to vary widely by hospital.

267 "Home" intensivists were those who continued to work in their usual ICU; "visitor" intensiv

268 ximal and distal limb enhancers nevertheless continued to work independently over a targeted transgen

269 Overlearning refers to the continued training of a skill after performance improvem

270 Here, we analyzed the continued trajectory of these measures out to 2 years an

271 mobile DNAs are self-propagating, and their continued transposition is a source of both heritable st

272 The study began in 1997, with continued treatment and follow-up through June 1, 2011.

273 Only 4.3% of study participants continued treatment with fenofibrate following completio

274 tions during the previous 12 months, despite continued treatment.

275 tment periods for subjects randomized to (1) continued twice daily fluticasone (F), (2) once daily fl

276 s an asthenospheric drag force, which drives continued underthrusting of the Indian continental litho

277 attachment, began in the third trimester and continued until 6 mo postpartum.

278 any specimen at week 4, biweekly collection continued until all specimens tested negative.

279 e treatment with bevacizumab monotherapy was continued until progressive disease without significant

280 patients with metastatic disease, treatment continued until radiologic, clinical, or prostate-specif

281 This intermittent sunitinib dosing continued until Response Evaluation Criteria in Solid Tu

282 c in association with global glaciations and continued until the end of the Lomagundi carbon isotope

283 ated by 0.6 mg/day each week for 5 weeks and continued until week 16.

284 Positive effects continued up to 16 weeks.

285 ty building, to ensure acceptance of IPV and continued uptake of OPV.

286 These findings support the continued use of direct oral anticoagulants.

287 nd 4.3 (2.9-7.6) per 100 000 population with continued use of longer therapy-ie, the short-course reg

288 resistant tuberculosis by 2024 compared with continued use of longer therapy.

289 10 y after adjustment for baseline zBMI.The continued use of restrictive feeding practices at age 10

290 ICU patients resulting from chronic effects, continued use, or withdrawal.

291 To ensure continued usefulness, future directions in therapy and h

292 photochemical products in the dark or under continued UV irradiation both resulted in nucleation and

293 n, eribulin, and paclitaxel), based on their continued viability, which was accompanied with an enhan

294 centage of children treated with ondansetron continued vomiting after the administration of the thera

295 Continued warming of the Arctic Ocean in coming decades

296 To understand whether these trends continued, we updated our assessment to include the diag

297 Continued weakening of the upper-ocean overturning is li

298 Despite continued widespread use, the genomic effects of cisplat

299 d, of those patients, from 4465 patients who continued with a median follow-up of 11.1 months in 2 OL

300 , and modeling skill, while also encouraging continued work on their mechanistic underpinnings.